Edition:
India

People: Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

52.28USD
1:30am IST
Change (% chg)

$0.34 (+0.65%)
Prev Close
$51.94
Open
$51.52
Day's High
$52.71
Day's Low
$51.31
Volume
130,516
Avg. Vol
186,430
52-wk High
$64.48
52-wk Low
$31.98

Lind, Kevin 

Mr. Kevin R. Lind is Executive Vice President and Chief Financial Officer of the Company. He has served as our Executive Vice President and Chief Financial Officer since June 2016. Previously, Mr. Lind was a Principal focused on healthcare at TPG Special Situations Partners, a global investment firm, from January 2009 to June 2016. Mr. Lind was a member of the TPG Pharma Partners effort at TPG-Axon, a global investment firm, from 2006 to 2008. He served in various capacities as a healthcare investment banker at Lehman Brothers, Inc., a former global financial services firm, from 1998 to 2002 and 2004 to 2006. Mr. Lind received a B.S. from Stanford University in Biological Sciences and an M.B.A. from UCLA Anderson School of Management.

Basic Compensation

Total Annual Compensation, USD 648,565
Restricted Stock Award, USD --
Long-Term Incentive Plans, USD --
All Other, USD 2,412,480
Fiscal Year Total, USD 3,061,040

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tina Nova

361,363

Amit Munshi

6,863,440

Kevin Lind

3,061,040

Steven Spector

3,112,620

Vincent Aurentz

3,163,930

Preston Klassen

3,079,840
As Of  31 Dec 2018